Finance

Lists
048410:KOSDAQ
Hyundai Bioscience Co Ltd
â‚©7,090.00
+4.26%
(+290.00) 1D
Sep 21, 3:30:04 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 048410...
Open
â‚©6,830
High
â‚©7,110
Low
â‚©6,780
Mkt. cap
684.22B
Avg. vol.
1.33M
Volume
997.88K
52-wk high
â‚©21,500
52-wk low
â‚©4,565
EPS
-â‚©298
Shares outstanding
96.51M
No. of employees
69
Open
â‚©6,830
High
â‚©7,110
Low
â‚©6,780
Mkt. cap
684.22B
Avg. vol.
1.33M
Volume
997.88K
52-wk high
â‚©21,500
52-wk low
â‚©4,565
EPS
-â‚©298
Shares outstanding
96.51M
No. of employees
69
About Hyundai Bioscience Co Ltd
CEO-
Employees69
Founded2000
Headquarters-
SectorPersonal care products
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
553.06M
-
324.68M
520.40M
Cost of goods sold
599.23M
-
401.27M
684.66M
Cost of revenue
599.23M
-
401.27M
684.66M
Research and development expenses
-
-
5.74B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.57B
-
-1.32B
5.37B
Operating expense
4.57B
-
4.59B
5.37B
Total operating expenses
5.17B
-
4.99B
6.06B
Operating income
-4.62B
-
-4.66B
-5.54B
Other non operating income
96.21M
-
554.81M
-1.63B
EBT including unusual items
-7.00B
-
-5.31B
-7.58B
EBT excluding unusual items
-7.00B
-
-5.04B
-7.58B
Income tax expense
-41.50K
-
-
1.82B
Effective tax rate
-
-
-
-24.00%
Other operating expenses
-
-
13.53M
-
Net income
-7.00B
-
-5.31B
-11.56B
Net profit margin
-1,265.22%
-
-1,636.30%
-2,221.19%
Earnings per share
-
-
-
-
Interest and investment income
-
-
522.09M
-
Interest expense
-
-
-1.00B
-
Net interest expenses
-
-
-480.17M
-
Depreciation and amortization charges
-
-
286.20M
-
EBITDA
-4.27B
-
-4.32B
-5.16B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps